ster

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry
Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry
ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
Read All Our News >

Pharma News

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma
Diabetes drugs less affordable, less available in lower income countries
Astellas Announces Positive Topline Results for Global Phase 3 Trial of Roxadustat in Chronic Kidney Disease (CKD) Patients with Anemia not on Dialysis
Read All Pharma News >

New Products &Services

Anti-Parasite Library
Covalent Inhibitors Library
Anti-HIV1 Library
KDM Library